Search research articles
Contact Us
Filters
Showing results (711-720 of 730) with videos related to
Page
of 73
Sort By:
Conservation Biology : the Journal of the Society for Conservation Biology
|
December 13, 2022
Quantifying and mapping species threat abatement opportunities to support national target setting
Louise Mair, Eduardo Amorim, Monira Bicalho, et al.
Clinical Transplants
|
July 22, 2008
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis
M Ozawa, P I Terasaki, R Castro, et al.
International Journal of Cancer
|
September 7, 2024
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study)
Chiara Ciccarese, Thomas Büttner, Linda Cerbone, et al.
Malaria Journal
|
December 23, 2025
Safety, tolerability, and efficacy of high versus low-dose, short versus long-course daily primaquine for the radical cure of uncomplicated Plasmodium vivax malaria in children under 15 years of age: an open-label, non-inferiority, randomized controlled trial (CHILDPRIM)
Ana Luisa O Pacheco, Aretha G Omena, Djane C Baía-da-Silva, et al.
The New England Journal of Medicine
|
January 17, 2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
Alejandro Llanos-Cuentas, Marcus V G Lacerda, Tran T Hien, et al.
Plos Neglected Tropical Diseases
|
May 18, 2021
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study)
Jose Diego Brito-Sousa, Felipe Murta, Sheila Vitor-Silva, et al.
Science Translational Medicine
|
March 24, 2012
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics
Christopher M Tan, Alex G Therien, Jun Lu, et al.
Cancer Immunology, Immunotherapy : CII
|
May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
Matteo Santoni, Zin W Myint, Thomas Büttner, et al.
The New England Journal of Medicine
|
January 17, 2019
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
Marcus V G Lacerda, Alejandro Llanos-Cuentas, Srivicha Krudsood, et al.
Clinical Genitourinary Cancer
|
April 16, 2023
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
Matteo Santoni, Francesco Massari, Zin W Myint, et al.
Page
of 73
Search research articles
Search
Showing results (711-720 of 730) with videos related to
Sort By:
Page
of 73
Conservation Biology : the Journal of the Society for Conservation Biology
|
December 13, 2022
Quantifying and mapping species threat abatement opportunities to support national target setting
Louise Mair, Eduardo Amorim, Monira Bicalho, et al.
Clinical Transplants
|
July 22, 2008
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis
M Ozawa, P I Terasaki, R Castro, et al.
International Journal of Cancer
|
September 7, 2024
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study)
Chiara Ciccarese, Thomas Büttner, Linda Cerbone, et al.
Malaria Journal
|
December 23, 2025
Safety, tolerability, and efficacy of high versus low-dose, short versus long-course daily primaquine for the radical cure of uncomplicated Plasmodium vivax malaria in children under 15 years of age: an open-label, non-inferiority, randomized controlled trial (CHILDPRIM)
Ana Luisa O Pacheco, Aretha G Omena, Djane C Baía-da-Silva, et al.
The New England Journal of Medicine
|
January 17, 2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
Alejandro Llanos-Cuentas, Marcus V G Lacerda, Tran T Hien, et al.
Plos Neglected Tropical Diseases
|
May 18, 2021
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study)
Jose Diego Brito-Sousa, Felipe Murta, Sheila Vitor-Silva, et al.
Science Translational Medicine
|
March 24, 2012
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics
Christopher M Tan, Alex G Therien, Jun Lu, et al.
Cancer Immunology, Immunotherapy : CII
|
May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
Matteo Santoni, Zin W Myint, Thomas Büttner, et al.
The New England Journal of Medicine
|
January 17, 2019
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
Marcus V G Lacerda, Alejandro Llanos-Cuentas, Srivicha Krudsood, et al.
Clinical Genitourinary Cancer
|
April 16, 2023
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
Matteo Santoni, Francesco Massari, Zin W Myint, et al.
Page
of 73